These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 38438865)

  • 1. Association of serum asprosin with metabolic dysfunction-associated fatty liver disease in older adult type 2 diabetic patients: a cross-sectional study.
    Cui J; Liu Y; Li M; Yin J; Yang J; Xu L
    BMC Endocr Disord; 2024 Mar; 24(1):27. PubMed ID: 38438865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum isthmin-1 is a potential biomarker for metabolic dysfunction associated fatty liver disease in patients with metabolic syndrome and type 2 diabetes mellitus.
    Lei X; Chen H; Xu Y; Yang Z; Zhang L; Wang C; Du H
    BMJ Open Diabetes Res Care; 2024 Sep; 12(5):. PubMed ID: 39322582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction and Validation of Metabolic Dysfunction-Associated Fatty Liver Disease Using Insulin Resistance-Related Indices in the Japanese Population.
    Moriyama K; Inoue N; Imai J; Masuda Y; Yamada C; Kishimoto N; Takashimizu S; Kubo A; Nishizaki Y
    Metab Syndr Relat Disord; 2023 Nov; 21(9):489-496. PubMed ID: 37878804
    [No Abstract]   [Full Text] [Related]  

  • 4. A study of the relationship between serum asprosin levels and MAFLD in a population undergoing physical examination.
    Lv D; Wang Z; Meng C; Li Y; Ji S
    Sci Rep; 2024 May; 14(1):11170. PubMed ID: 38750109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated small dense low-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio is associated with an increased risk of metabolic dysfunction associated fatty liver disease in Chinese patients with type 2 diabetes mellitus.
    Yang S; Xu J
    J Diabetes Investig; 2024 May; 15(5):634-642. PubMed ID: 38251808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the diagnostic value between triglyceride-glucose index and triglyceride to high-density lipoprotein cholesterol ratio in metabolic-associated fatty liver disease patients: a retrospective cross-sectional study.
    Liu Z; He H; Dai Y; Yang L; Liao S; An Z; Li S
    Lipids Health Dis; 2022 Jun; 21(1):55. PubMed ID: 35752830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The metabolic profiles and body composition of non-obese metabolic associated fatty liver disease.
    Zhang Y; Xiang L; Qi F; Cao Y; Zhang W; Lv T; Zhou X
    Front Endocrinol (Lausanne); 2024; 15():1322563. PubMed ID: 38375190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Study of Biomarkers Associated with Metabolic Dysfunction-Associated Fatty Liver Disease in Patients with Type 2 Diabetes.
    Efrem IC; Moța M; Vladu IM; Mitrea A; Clenciu D; Timofticiuc DCP; Diaconu ID; Turcu A; Crișan AE; Geormăneanu C; Glodeanu AD; Mahler B; Tudor MS; Amzolini AM; Micu SE; Barău Abu Alhija A; Mită A; Filip MM; Forțofoiu M
    Diagnostics (Basel); 2022 Oct; 12(10):. PubMed ID: 36292115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic (Dysfunction)-Associated Fatty Liver Disease in Chinese Patients with Type 2 Diabetes from a Subcenter of the National Metabolic Management Center.
    Guan C; Fu S; Zhen D; Yang K; An J; Wang Y; Ma C; Jiang N; Zhao N; Liu J; Yang F; Tang X
    J Diabetes Res; 2022; 2022():8429847. PubMed ID: 35127953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The correlation between serum asprosin and left ventricular diastolic dysfunction in elderly patients with type 2 diabetes mellitus in the community.
    Liang D; Shi G; Xu M; Yin J; Liu Y; Yang J; Xu L
    J Diabetes Investig; 2024 May; 15(5):608-613. PubMed ID: 38363189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of asprosin and Nrg-4 with type 2 diabetes Mellitus Complicated with Coronary Heart Disease and the Diagnostic Value.
    Zhong M; Tian X; Sun Q; Li L; Lu Y; Feng Z; Gao Y; Li S
    BMC Endocr Disord; 2023 Mar; 23(1):61. PubMed ID: 36915073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum iron is closely associated with metabolic dysfunction-associated fatty liver disease in type 2 diabetes: A real-world study.
    Wang JW; Jin CH; Ke JF; Ma YL; Wang YJ; Lu JX; Li MF; Li LX
    Front Endocrinol (Lausanne); 2022; 13():942412. PubMed ID: 36133303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association Between Serum Asprosin and Diabetic Nephropathy in Patients with Type 2 Diabetes Mellitus in the Community: A Cross-Sectional Study.
    Xu L; Cui J; Li M; Wu Q; Liu M; Xu M; Shi G; Yin J; Yang J
    Diabetes Metab Syndr Obes; 2022; 15():1877-1884. PubMed ID: 35757196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel metabolic classification for extrahepatic complication of metabolic associated fatty liver disease: A data-driven cluster analysis with international validation.
    Ye J; Zhuang X; Li X; Gong X; Sun Y; Wang W; Feng S; Wu T; Zhong B
    Metabolism; 2022 Nov; 136():155294. PubMed ID: 35995280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations Between GGT/HDL and MAFLD: A Cross-Sectional Study.
    Xing Y; Chen J; Liu J; Ma H
    Diabetes Metab Syndr Obes; 2022; 15():383-394. PubMed ID: 35177915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood lactate levels are associated with an increased risk of metabolic dysfunction-associated fatty liver disease in type 2 diabetes: a real-world study.
    Ma YL; Ke JF; Wang JW; Wang YJ; Xu MR; Li LX
    Front Endocrinol (Lausanne); 2023; 14():1133991. PubMed ID: 37223022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between circulating asprosin levels and carotid atherosclerotic plaque in patients with type 2 diabetes.
    Deng X; Zhao Z; Zhao L; Wang C; Li Y; Cai Z; Li H; Gu T; Xia Y; Zhang Z; Wang D; Yang L; Yuan G
    Clin Biochem; 2022; 109-110():44-50. PubMed ID: 35961579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum concentration of asprosin in new-onset type 2 diabetes.
    Naiemian S; Naeemipour M; Zarei M; Lari Najafi M; Gohari A; Behroozikhah MR; Heydari H; Miri M
    Diabetol Metab Syndr; 2020; 12():65. PubMed ID: 32714446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Establishment and Analysis of Risk Prediction Model for Metabolic Dysfunction-Associated Fatty Liver Disease in Physical Examination Population].
    Xia B; He H; Qin K; Li SQ; An ZM
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 May; 54(3):591-595. PubMed ID: 37248589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gamma-glutamyl transferase to high-density lipoprotein cholesterol ratio is a more powerful marker than TyG index for predicting metabolic syndrome in patients with type 2 diabetes mellitus.
    Gong S; Gan S; Zhang Y; Zhou H; Zhou Q
    Front Endocrinol (Lausanne); 2023; 14():1248614. PubMed ID: 37854188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.